Carrera Capital Advisors Buys 3,063 Shares of Colgate-Palmolive Company $CL

Carrera Capital Advisors grew its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 7.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,077 shares of the company’s stock after buying an additional 3,063 shares during the period. Colgate-Palmolive makes up 0.8% of Carrera Capital Advisors’ portfolio, making the stock its 26th biggest position. Carrera Capital Advisors’ holdings in Colgate-Palmolive were worth $3,916,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. Brighton Jones LLC lifted its holdings in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares in the last quarter. GAMMA Investing LLC raised its position in Colgate-Palmolive by 14.2% in the 1st quarter. GAMMA Investing LLC now owns 11,797 shares of the company’s stock valued at $1,105,000 after buying an additional 1,468 shares during the last quarter. Oppenheimer Asset Management Inc. raised its position in Colgate-Palmolive by 69.9% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 23,854 shares of the company’s stock valued at $2,235,000 after buying an additional 9,815 shares during the last quarter. Golden State Wealth Management LLC raised its position in Colgate-Palmolive by 266.9% in the 1st quarter. Golden State Wealth Management LLC now owns 521 shares of the company’s stock valued at $49,000 after buying an additional 379 shares during the last quarter. Finally, Pure Financial Advisors LLC raised its position in Colgate-Palmolive by 57.1% in the 1st quarter. Pure Financial Advisors LLC now owns 7,942 shares of the company’s stock valued at $744,000 after buying an additional 2,886 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.6%

Shares of Colgate-Palmolive stock opened at $78.01 on Friday. The firm has a 50-day moving average of $81.33 and a 200-day moving average of $86.94. The stock has a market cap of $63.05 billion, a PE ratio of 21.91, a PEG ratio of 4.60 and a beta of 0.34. Colgate-Palmolive Company has a 52-week low of $76.68 and a 52-week high of $100.18. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive’s quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.91 earnings per share. As a group, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.7%. Colgate-Palmolive’s payout ratio is presently 58.43%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CL shares. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Friday. Morgan Stanley decreased their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Wells Fargo & Company decreased their target price on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research note on Thursday, September 25th. Piper Sandler began coverage on shares of Colgate-Palmolive in a research note on Friday, October 3rd. They issued a “neutral” rating and a $84.00 target price for the company. Finally, Bank of America decreased their target price on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $91.50.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.